Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 231-241, July 2007

Effects of leptin on cardiovascular physiology

  • Johnathan D. Tune, PhD

      Affiliations

    • Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA
  • ,
  • Robert V. Considine, PhD

      Affiliations

    • Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA
    • Corresponding Author InformationCorresponding author: Robert V. Considine, PhD, Indiana University School of Medicine, 541 N. Clinical Dr., Rm CL455, Indianapolis, Indiana 46202. Tel: 317-278-2389; fax: 317-278-0658.

Received 20 December 2006; accepted 5 April 2007.

Abstract 

Since the discovery of leptin, numerous studies have established a central role for this adipose tissue hormone in the regulation of body weight. Further it is now recognized that obesity is a state of hyperleptinemia resulting from increased synthesis and release of leptin from the greater adipose tissue mass present in this condition. Leptin has been implicated in the regulation of a number of physiological processes in addition to body weight homeostasis, and in many cases the hyperleptinemia of obesity may result in pathologic consequences. Leptin appears to have a central role in the development of obesity related hypertension and a number of observations implicate leptin as contributing to atherogenesis and atherosclerosis. Although significant progress has been made in our understanding of the pathologic effects of leptin on cardiovascular function, additional work remains to be done to fully understand the consequences of hyperleptinemia on cardiovascular physiology.

Keywords: Obesity, hypertension, atherosclerosis, thrombosis, cardiomyocytes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study has been supported by National Institutes of Health Grants DK51140 (R.V.C.) and HL67804 (J.D.T.) and a grant from the American Diabetes Association (R.V.C.).Conflict of interest: none.

PII: S1933-1711(07)00086-1

doi:10.1016/j.jash.2007.04.001

Journal of the American Society of Hypertension
Volume 1, Issue 4 , Pages 231-241, July 2007